Literature DB >> 3373003

Radioassays for quantitation of intact complement proteins C2 and B in human serum.

T J Oglesby1, A Ueda, J E Volanakis.   

Abstract

Availability of polyclonal and monoclonal antibodies recognizing determinants on the major cleavage fragments of complement proteins C2 and B enabled development of sensitive radioassays which can be used to quantitate the intact proteins in human sera. Changes in C2 and B concentrations indicative of classical or alternative pathway activation, or both, were seen in normal serum after incubation with complement activators. We determined the normal range (mean +/- 2 SD) of C2 concentration to be 11-35 micrograms/ml in 32 healthy individuals, and that of protein B to be 74-286 micrograms/ml. Sera from patients with systemic lupus erythematosus (SLE), septic shock, infections, and following orthopedic surgery were then assayed. Mean protein B concentration was significantly higher in SLE sera (P = 0.002) and in the infected and post-operative (acute-phase) sera (P less than 0.001), and the mean C2 concentration in the septic shock group (P less than 0.001) was significantly lower than the mean of healthy individuals. Intact C2 was not detected in known C2-deficient individuals. These assays allow parallel quantitation of the structurally and functionally homologous proteins of the classical (C2) and alternative (B) pathways, which is of interest in patients with genetic and acquired hypocomplementemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373003     DOI: 10.1016/0022-1759(88)90082-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Molecular defects leading to human complement component C6 deficiency in an African-American family.

Authors:  Z B Zhu; K Totemchokchyakarn; T P Atkinson; J E Volanakis
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 2.  Properdin: New roles in pattern recognition and target clearance.

Authors:  Claudia Kemper; Dennis E Hourcade
Journal:  Mol Immunol       Date:  2008-08-08       Impact factor: 4.407

3.  Properdin and factor h: opposing players on the alternative complement pathway "see-saw".

Authors:  Lubna Kouser; Munirah Abdul-Aziz; Annapurna Nayak; Cordula M Stover; Robert B Sim; Uday Kishore
Journal:  Front Immunol       Date:  2013-04-23       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.